We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, March 1–June 30, 2020.
- Authors
Acosta, Anna M; Mathis, Adria L; Budnitz, Daniel S; Geller, Andrew I; Chai, Shua J; Alden, Nisha B; Meek, James; Anderson, Evan J; Ryan, Patricia; Kim, Sue; Como-Sabetti, Kathryn; Torres, Salina; Dufort, Elizabeth; Bennett, Nancy M; Billing, Laurie M; Sutton, Melissa; Talbot, H Keipp; George, Andrea; Pham, Huong; Hall, Aron J
- Abstract
Using a coronavirus disease 2019 (COVID-19)–associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1–June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased.
- Subjects
COVID-19; COVID-19 treatment; INVESTIGATIONAL therapies; HOSPITAL patients; HOSPITAL care
- Publication
Open Forum Infectious Diseases, 2020, Vol 7, Issue 11, p1
- ISSN
2328-8957
- Publication type
Article
- DOI
10.1093/ofid/ofaa528